Anthony Buisson

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

Geert D’Haens, Séverine Vermeire, Guy Lambrecht et al. · Gastroenterology · 2018 · 295 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Infliximab Dose +8

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools

Anthony Buisson, Florent Gonzalez, Florian Poullenot et al. · Inflammatory Bowel Diseases · 2017 · 223 citations · Full text

Diffusion-Weighted Magnetic Resonance Imaging in Ileocolonic Crohn's Disease: Validation of Quantitative Index of Activity

Constance Hordonneau, Anthony Buisson, Julien Scanzi et al. · The American Journal of Gastroenterology · 2013 · 213 citations

Diffusion‐weighted magnetic resonance imaging for detecting and assessing ileal inflammation in <scp>C</scp>rohn's disease

Anthony Buisson, Aurélie Joubert, P.F. Montoriol et al. · Alimentary Pharmacology & Therapeutics · 2013 · 195 citations · Full text

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

Aurélien Amiot, Jean–Charles Grimaud, Laurent Peyrin‐Biroulet et al. · Clinical Gastroenterology and Hepatology · 2016 · 189 citations

Inflammation, Anti-inflammatory, Immunology +6